AU2001280702A1 - Compounds and methods for treatment and diagnosis of chlamydial infection - Google Patents

Compounds and methods for treatment and diagnosis of chlamydial infection

Info

Publication number
AU2001280702A1
AU2001280702A1 AU2001280702A AU2001280702A AU2001280702A1 AU 2001280702 A1 AU2001280702 A1 AU 2001280702A1 AU 2001280702 A AU2001280702 A AU 2001280702A AU 2001280702 A AU2001280702 A AU 2001280702A AU 2001280702 A1 AU2001280702 A1 AU 2001280702A1
Authority
AU
Australia
Prior art keywords
diagnosis
compounds
treatment
methods
chlamydial infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2001280702A
Other versions
AU2001280702B2 (en
AU2001280702B8 (en
AU2001280702B9 (en
Inventor
Ajay Bhatia
Steven P. Fling
Peter Probst
Yasir A. W. Skeiky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corixa Corp
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/620,412 external-priority patent/US6448234B1/en
Priority claimed from US09/841,132 external-priority patent/US20020061848A1/en
Application filed by Corixa Corp filed Critical Corixa Corp
Application granted granted Critical
Publication of AU2001280702B9 publication Critical patent/AU2001280702B9/en
Publication of AU2001280702A1 publication Critical patent/AU2001280702A1/en
Publication of AU2001280702B2 publication Critical patent/AU2001280702B2/en
Publication of AU2001280702B8 publication Critical patent/AU2001280702B8/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2001280702A 2000-07-20 2001-07-20 Compounds and methods for treatment and diagnosis of chlamydial infection Ceased AU2001280702B8 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US09/620,412 US6448234B1 (en) 1998-12-08 2000-07-20 Compounds and methods for treatment and diagnosis of chlamydial infection
US09/620,412 2000-07-20
US09/841,132 2001-04-23
US09/841,132 US20020061848A1 (en) 2000-07-20 2001-04-23 Compounds and methods for treatment and diagnosis of chlamydial infection
PCT/US2001/023121 WO2002008267A2 (en) 2000-07-20 2001-07-20 Compounds and methods for treatment and diagnosis of chlamydial infection

Publications (4)

Publication Number Publication Date
AU2001280702B9 AU2001280702B9 (en) 2002-02-05
AU2001280702A1 true AU2001280702A1 (en) 2002-05-02
AU2001280702B2 AU2001280702B2 (en) 2008-01-24
AU2001280702B8 AU2001280702B8 (en) 2008-02-28

Family

ID=27088713

Family Applications (2)

Application Number Title Priority Date Filing Date
AU8070201A Pending AU8070201A (en) 2000-07-20 2001-07-20 Compounds and methods for treatment and diagnosis of chlamydial infection
AU2001280702A Ceased AU2001280702B8 (en) 2000-07-20 2001-07-20 Compounds and methods for treatment and diagnosis of chlamydial infection

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU8070201A Pending AU8070201A (en) 2000-07-20 2001-07-20 Compounds and methods for treatment and diagnosis of chlamydial infection

Country Status (25)

Country Link
US (9) US20020061848A1 (en)
EP (1) EP1307564B1 (en)
JP (1) JP2004513622A (en)
KR (1) KR20030016423A (en)
CN (1) CN100467600C (en)
AT (1) ATE373092T1 (en)
AU (2) AU8070201A (en)
BR (1) BR0112602A (en)
CA (1) CA2418282A1 (en)
CY (1) CY1107796T1 (en)
CZ (1) CZ2003480A3 (en)
DE (1) DE60130468T2 (en)
DK (1) DK1307564T3 (en)
ES (1) ES2294018T3 (en)
HK (1) HK1067381A1 (en)
HU (1) HUP0400477A3 (en)
IL (2) IL153904A0 (en)
MX (1) MXPA03000564A (en)
NO (1) NO20030252L (en)
NZ (3) NZ523628A (en)
PL (1) PL209107B1 (en)
PT (1) PT1307564E (en)
RU (2) RU2003104976A (en)
WO (1) WO2002008267A2 (en)
ZA (1) ZA200300719B (en)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629167A (en) * 1994-04-19 1997-05-13 Biocine S.P.A. Detection of antibodies against Chlamydia trachomatis pgp3 antigen in patient sera by enzyme-linked immunosorbent assay
US7459524B1 (en) 1997-10-02 2008-12-02 Emergent Product Development Gaithersburg Inc. Chlamydia protein, sequence and uses thereof
AU5365999A (en) 1998-08-20 2000-03-14 Connaught Laboratories Limited Nucleic acid molecules encoding pomp91a protein of (chlamydia)
US6686339B1 (en) 1998-08-20 2004-02-03 Aventis Pasteur Limited Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia
WO2000011181A1 (en) 1998-08-20 2000-03-02 Connaught Laboratories Limited NUCLEIC ACID MOLECULES ENCODING INCLUSION MEMBRANE PROTEIN C OF $i(CHLAMYDIA)
US6649370B1 (en) 1998-10-28 2003-11-18 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
US6607730B1 (en) 1998-11-02 2003-08-19 Aventis Pasteur Limited/Aventis Pasteur Limitee Chlamydia antigens and corresponding DNA fragments and uses thereof
US20020094340A1 (en) 1998-12-01 2002-07-18 Andrew D. Murdin Chlamydia antigens and corresponding dna thereof
EP1144642B1 (en) 1998-12-08 2010-05-26 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US6555115B1 (en) * 1998-12-08 2003-04-29 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US20020061848A1 (en) * 2000-07-20 2002-05-23 Ajay Bhatia Compounds and methods for treatment and diagnosis of chlamydial infection
US20080213264A1 (en) * 1998-12-08 2008-09-04 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
GB9828000D0 (en) 1998-12-18 1999-02-10 Chiron Spa Antigens
US7297341B1 (en) 1998-12-23 2007-11-20 Sanofi Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
ATE384738T1 (en) 1998-12-28 2008-02-15 Aventis Pasteur CHLAMYDIA ANTIGENS, CORRESPONDING DNA FRAGMENTS AND THEIR USES
US6808713B1 (en) 1998-12-28 2004-10-26 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
GB9902555D0 (en) 1999-02-05 1999-03-24 Neutec Pharma Plc Medicament
EP2172214A3 (en) 1999-03-12 2011-03-16 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
ATE375391T1 (en) 1999-05-03 2007-10-15 Sanofi Pasteur Ltd CHLAMYDIA ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND THEIR USES
WO2001021804A1 (en) 1999-09-20 2001-03-29 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
US6632663B1 (en) 1999-09-22 2003-10-14 Aventis Pasteur Limited DNA immunization against chlamydia infection
EP1240331B1 (en) 1999-12-22 2010-04-07 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
EP2192128A3 (en) 2000-04-21 2010-09-22 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US6919187B2 (en) * 2000-04-21 2005-07-19 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
DE60125350T2 (en) 2000-05-08 2007-07-12 Sanofi Pasteur Ltd., Toronto CHLAMYDIA ANTIGENES, CORRESPONDING DNA FRAGMENTS AND ITS USES
EP1297005B1 (en) 2000-07-03 2009-08-26 Novartis Vaccines and Diagnostics S.r.l. Immunisation against chlamydia pneumoniae
US7537772B1 (en) * 2000-10-02 2009-05-26 Emergent Product Development Gaithersburg Inc. Chlamydia protein, gene sequence and the uses thereof
US7731980B2 (en) * 2000-10-02 2010-06-08 Emergent Product Development Gaithersburg Inc. Chlamydia PMP proteins, gene sequences and uses thereof
US20030059896A1 (en) * 2000-12-21 2003-03-27 Shire Biochem Inc. Novel chlamydia antigens and corresponding DNA fragments
GB2370838A (en) * 2001-01-06 2002-07-10 Benedikt Timmerman Immunogenic complex
EP1463520B1 (en) * 2001-12-12 2008-09-03 Novartis Vaccines and Diagnostics S.r.l. Immunisation against chlamydia trachomatis
GB0203403D0 (en) 2002-02-13 2002-04-03 Chiron Spa Chlamydia cytotoxic-T cell epitopes
JP4896715B2 (en) * 2003-06-26 2012-03-14 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド Immunogenic composition against Chlamydiatrachomatis
US20080019994A1 (en) * 2003-11-20 2008-01-24 Robert Brunham Immunization Against Chlamydia Infection
WO2006104890A2 (en) 2005-03-31 2006-10-05 Glaxosmithkline Biologicals Sa Vaccines against chlamydial infection
US8541007B2 (en) 2005-03-31 2013-09-24 Glaxosmithkline Biologicals S.A. Vaccines against chlamydial infection
CA2608278A1 (en) * 2005-05-12 2006-12-28 Guido Grandi Immunogenic compositions for chlamydia trachomatis
WO2007030879A1 (en) * 2005-09-13 2007-03-22 Diatech Pty Ltd Diagnostic markers and uses therefor
EP1981905B1 (en) * 2006-01-16 2016-08-31 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Chlamydia vaccine
EP1970708A1 (en) * 2007-03-07 2008-09-17 Mikrogen Molekularbiologische Entwicklungs-GmbH Bio chip and method for selective proof of Chlamydia trachomatis infections
WO2008156729A2 (en) * 2007-06-14 2008-12-24 Emergent Product Development Gaithersburg Inc. Vaccines against chlamydia infection
EP2185577A4 (en) * 2007-08-03 2010-09-22 Harvard College Chlamydia antigens
CA2744739A1 (en) * 2007-12-03 2009-06-11 President And Fellows Of Harvard College Chlamydia antigens
RU2011140508A (en) 2009-03-06 2013-04-20 Новартис Аг Chlamydia antigens
EP2557156B1 (en) 2010-03-23 2015-02-11 Wako Pure Chemical Industries, Ltd. Primer and probe for detecting chlamydia trachomatis, and method for detecting chlamydia trachomatis using same
CA2849391A1 (en) * 2010-10-20 2012-04-26 Genocea Biosciences, Inc. Chlamydia antigens and uses thereof
US20130095487A1 (en) * 2011-10-18 2013-04-18 University Of South Florida Interferon-Gamma Response as a Diagnostic Test for Persistent Chlamydial Infections
BR112015013135A2 (en) * 2012-12-05 2017-09-26 Thevax Genetics Vaccine Co Ltd fusion proteins for use as immunogenic enhancers to induce antigen specific t cell responses
CN113801191B (en) * 2021-08-18 2022-05-17 南京大学 Polypeptide probe for detecting chlamydia and application thereof

Family Cites Families (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4118469A (en) * 1976-04-27 1978-10-03 Research Corporation Antigen for trachoma lymphogranuloma venereum (LGV) and non-gonococcal urethritis (NGU)
US4497899A (en) * 1982-04-12 1985-02-05 Abbott Laboratories Immunoassay for Chlamydia trachomatis antigens
US4497900A (en) 1982-04-12 1985-02-05 Abbott Laboratories Immunoassay for Neisseria gonorrhoeae antigens
US4497863A (en) * 1984-03-07 1985-02-05 Milliken Research Corporation Laminated weft insertion fabric
ATE143414T1 (en) 1985-01-14 1996-10-15 Chiron Corp MAIN PROTEIN OF THE OUTER MEMBRANE OF CHLAMYDIA
US5785973A (en) * 1988-02-01 1998-07-28 Praxis Biologics, Inc. Synthetic peptides representing a T-cell epitope as a carrier molecule for conjugate vaccines
EP0348725A3 (en) 1988-06-29 1990-10-24 Miles Inc. Species-specific epitode of chlamydia trachomatis and antibodies that recognize the same
US5539084A (en) * 1989-02-17 1996-07-23 Coselco Mimotopes Pty. Ltd. Method for the use and synthesis of peptides
US5869608A (en) * 1989-03-17 1999-02-09 The United States Of America As Represented By The Department Of Health And Human Services Nucleotide and amino acid sequences of the four variable domains of the major outer membrane proteins of Chlamydia trachomatis
US5166053A (en) * 1990-02-23 1992-11-24 Miles Inc. Specimen adequacy control for chlamydia assays
JP3018553B2 (en) * 1990-05-08 2000-03-13 日立化成工業株式会社 Chlamydia trachomatis antibody measurement method and preparation for diagnosing chlamydia trachomatis infection
US5725863A (en) 1991-09-06 1998-03-10 The United States Of America As Represented By The Secretary Of Agriculture Polypeptides useful in prevention of chlamydia infection
CZ282235B6 (en) * 1992-06-25 1997-06-11 Smithkline Beecham Biologicals (S.A.) Inoculation substance, process of its preparation and use
AU669000B2 (en) 1992-09-18 1996-05-23 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Synthetic peptide vaccine for chlamydia trachomatis
US5549978A (en) * 1992-10-30 1996-08-27 Kabushiki Kaisha Toshiba Magnetoresistance effect element
US5629167A (en) * 1994-04-19 1997-05-13 Biocine S.P.A. Detection of antibodies against Chlamydia trachomatis pgp3 antigen in patient sera by enzyme-linked immunosorbent assay
CN100365017C (en) 1994-09-20 2008-01-30 日立化成工业株式会社 Antigenic polypeptide of chlamydia pneumoniae
GB9626864D0 (en) 1996-12-24 1997-02-12 Smithkline Beecham Biolog Vaccine
GB9506863D0 (en) * 1995-04-03 1995-05-24 Smithkline Beecham Biolog Vaccines
GB9516293D0 (en) 1995-08-09 1995-10-11 Immunova Ltee Novel peptides and their use as vaccines
CN1223589A (en) * 1996-05-06 1999-07-21 美国拜尔公司 Feline vaccines containing chlamydia psittaci and method for making the same
AU723235B2 (en) 1996-07-12 2000-08-24 University Of Manitoba DNA immunization against Chlaymdia infection
US6464979B1 (en) 1996-09-12 2002-10-15 Aventis Pasteur Limited Chlamydial vaccines and methods of preparation thereof
WO2001023604A2 (en) 1999-09-28 2001-04-05 Infectio Diagnostic (I.D.I.) Inc. Highly conserved genes and their use to generate probes and primers for detection of microorganisms
US7459524B1 (en) * 1997-10-02 2008-12-02 Emergent Product Development Gaithersburg Inc. Chlamydia protein, sequence and uses thereof
JP4249279B2 (en) 1997-10-22 2009-04-02 デンカ生研株式会社 Chlamydia trachomatis major outer membrane protein and method for producing the same, chlamydia trachomatis antibody measuring method and antibody measuring reagent
PT1032674E (en) * 1997-11-21 2007-03-30 Serono Genetics Inst Sa (chlamydia pneumoniae) genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
EP1854885B9 (en) 1997-11-21 2011-03-16 Merck Serono Biodevelopment Chlamydia pneumoniae outer membrane polypeptide, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
AU754264B2 (en) * 1997-11-28 2002-11-07 Genset S.A. Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
US7041490B1 (en) * 1997-11-28 2006-05-09 Serono Genetics Institute, S.A. Chlamydia trachomatis polynucleotides and vectors, recombinant host cells, DNA chips or kits containing the same
JP4227302B2 (en) 1998-04-07 2009-02-18 コリクサ コーポレイション MYCOBACTERIUMUMBERBERCULOSIS antigen fusion protein and use thereof
SI1126876T1 (en) * 1998-10-16 2007-08-31 Glaxosmithkline Biolog Sa Adjuvant systems and vaccines
US6607730B1 (en) * 1998-11-02 2003-08-19 Aventis Pasteur Limited/Aventis Pasteur Limitee Chlamydia antigens and corresponding DNA fragments and uses thereof
AU1722300A (en) 1998-11-12 2000-05-29 Regents Of The University Of California, The Chlamydia pneumoniae genome sequence
EP1144642B1 (en) * 1998-12-08 2010-05-26 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US6565856B1 (en) * 1998-12-08 2003-05-20 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US6555115B1 (en) * 1998-12-08 2003-04-29 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US6432916B1 (en) * 1998-12-08 2002-08-13 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US20020061848A1 (en) 2000-07-20 2002-05-23 Ajay Bhatia Compounds and methods for treatment and diagnosis of chlamydial infection
US6448234B1 (en) * 1998-12-08 2002-09-10 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US6447779B1 (en) * 1998-12-08 2002-09-10 Corixa Corporation Compounds for the diagnosis of Chlamydial infection
US20080213264A1 (en) * 1998-12-08 2008-09-04 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US6166177A (en) * 1998-12-08 2000-12-26 Corixa Corporation Compounds and methods for the treatment and diagnosis of chlamydial infection
GB9828000D0 (en) 1998-12-18 1999-02-10 Chiron Spa Antigens
GB9902555D0 (en) 1999-02-05 1999-03-24 Neutec Pharma Plc Medicament
EP2172214A3 (en) 1999-03-12 2011-03-16 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
ATE375391T1 (en) 1999-05-03 2007-10-15 Sanofi Pasteur Ltd CHLAMYDIA ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND THEIR USES
US6811783B1 (en) * 1999-09-07 2004-11-02 Aventis Pasteur Limited Immunogenic compositions for protection against chlamydial infection
WO2001021804A1 (en) 1999-09-20 2001-03-29 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
US6632663B1 (en) 1999-09-22 2003-10-14 Aventis Pasteur Limited DNA immunization against chlamydia infection
EP1221051A4 (en) * 1999-10-14 2003-03-05 Univ Utah Res Found Resonant optical cavities for high-sensitivity, high-throughput biological sensors and methods
AU1481001A (en) * 1999-11-19 2001-05-30 Michigan State University Recombinant chlamydia vaccine
EP1240331B1 (en) 1999-12-22 2010-04-07 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
US20010048927A1 (en) * 2000-02-01 2001-12-06 Richard Stephens Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamydia
US6919187B2 (en) * 2000-04-21 2005-07-19 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US20020146776A1 (en) * 2000-04-21 2002-10-10 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
EP2192128A3 (en) * 2000-04-21 2010-09-22 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
DE60125350T2 (en) 2000-05-08 2007-07-12 Sanofi Pasteur Ltd., Toronto CHLAMYDIA ANTIGENES, CORRESPONDING DNA FRAGMENTS AND ITS USES
US6589361B2 (en) * 2000-06-16 2003-07-08 Applied Materials Inc. Configurable single substrate wet-dry integrated cluster cleaner
EP1297005B1 (en) 2000-07-03 2009-08-26 Novartis Vaccines and Diagnostics S.r.l. Immunisation against chlamydia pneumoniae
US6827189B2 (en) * 2000-07-20 2004-12-07 Zf Friedrichshafen Ag Electromagnetically actuated, single-surface friction coupling, without a rotor slip ring
US7731980B2 (en) * 2000-10-02 2010-06-08 Emergent Product Development Gaithersburg Inc. Chlamydia PMP proteins, gene sequences and uses thereof
US7537772B1 (en) * 2000-10-02 2009-05-26 Emergent Product Development Gaithersburg Inc. Chlamydia protein, gene sequence and the uses thereof
GB0103169D0 (en) * 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition
AU2002306849A1 (en) * 2001-03-21 2002-10-08 Elitra Pharmaceuticals, Inc. Identification of essential genes in microorganisms
WO2002079244A2 (en) * 2001-03-30 2002-10-10 University Of Manitoba Chlamydial protease-like activity factor responsible for degradation of host transcription factor
US20030199438A1 (en) * 2001-04-09 2003-10-23 Shaw Allan Christian Method for identification of proteins from intracellular bacteria
US20040029129A1 (en) * 2001-10-25 2004-02-12 Liangsu Wang Identification of essential genes in microorganisms
EP1463520B1 (en) * 2001-12-12 2008-09-03 Novartis Vaccines and Diagnostics S.r.l. Immunisation against chlamydia trachomatis
US7105171B2 (en) * 2002-03-07 2006-09-12 The Regents Of The University Of California Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia
JP4896715B2 (en) * 2003-06-26 2012-03-14 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド Immunogenic composition against Chlamydiatrachomatis
FR2869057B1 (en) * 2004-04-16 2006-06-02 Piscines Desjoyaux Sa Sa DEVICE FOR REALIZING A TOP OF CHAINAGE OF AN STAIRCASE
EP2314314A3 (en) * 2004-10-25 2011-05-11 Statens Serum Institut Chlamydia trachomatis antigens for vaccine and diagnostic use
US8541007B2 (en) * 2005-03-31 2013-09-24 Glaxosmithkline Biologicals S.A. Vaccines against chlamydial infection
WO2006104890A2 (en) * 2005-03-31 2006-10-05 Glaxosmithkline Biologicals Sa Vaccines against chlamydial infection
CA2608278A1 (en) * 2005-05-12 2006-12-28 Guido Grandi Immunogenic compositions for chlamydia trachomatis
US8481057B2 (en) * 2005-12-22 2013-07-09 Novartis Vaccines & Diagnostics Srl Chlamydial antigens
EP1981905B1 (en) * 2006-01-16 2016-08-31 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Chlamydia vaccine
US20080124338A1 (en) * 2006-09-22 2008-05-29 The Scripps Research Institute Methods for treatment of inflammatory disease and chlamydia infectious disease
US20100172927A1 (en) * 2006-10-04 2010-07-08 Mark Alderson Vaccines Against Chlamydial Infection
US7892567B2 (en) * 2007-10-01 2011-02-22 Board Of Regents, The University Of Texas System Methods and compositions for immunization against chlamydial infection and disease
EP2342215A4 (en) * 2008-10-09 2012-06-27 Univ Texas Methods and compositions for chlamydial antigens for diagnosis and treatment of chlamydial infection and disease
JP2012512257A (en) * 2008-12-17 2012-05-31 ジェノセア バイオサイエンシーズ， インコーポレイテッド Chlamydia antigen and uses thereof
RU2011140508A (en) * 2009-03-06 2013-04-20 Новартис Аг Chlamydia antigens
WO2011112670A2 (en) * 2010-03-09 2011-09-15 Board Of Regents, University Of Texas System Methods and compositions for chlamydial antigens for diagnosis and treatment of chlamydial infection and disease

Similar Documents

Publication Publication Date Title
AU2001280702A1 (en) Compounds and methods for treatment and diagnosis of chlamydial infection
HUP0400477A3 (en) Compounds and methods for treatment and diagnosis of chlamydial infection
PL355977A1 (en) Compounds and methods for treatment and diagnosis of chlamydial infection
HUP0400719A3 (en) Compounds and methods for treatment and diagnosis of chlamydial infection
AU1967501A (en) Device and method for improved diagnosis and treatment of cancer
AUPR638101A0 (en) Composition and method for treatment of disease
AU2002305400A1 (en) Medical device and methods of use for glaucoma treatment
AU2002323258A1 (en) Diagnosis and treatment of vascular disease
IL152553A0 (en) Compounds and methods for the treatment and prevention of bacterial infection
AU2001292737A1 (en) Treating microbial infection of skin lesions
IL145282A0 (en) Compositions and methods for treatment of staphylococcal infection
EP1144639A3 (en) Compounds and methods for the diagnosis and treatment of ehrlichia infection
AU2002326813A1 (en) Diagnosis and treatment of vascular disease
AU2001259507A1 (en) Compounds and methods for the diagnosis and treatment of ehrlichia infection
AU2002239485A1 (en) Methods for improved diagnosis and treatment of mycobacterial infections
AU2002220257A1 (en) Methods of treatment involving human mda-7
AUPQ474599A0 (en) Endoscope for surgical treatment of haemorrhoids
AU2002341880A1 (en) Diagnosis and treatment of vascular disease
AU4204700A (en) Compounds and methods for the diagnosis and treatment of (b. microti) infection
AU2001234831A1 (en) Magnetoliposome composition for targeted treatment of biological tissue and associated methods
AU2002341604A1 (en) Diagnosis and treatment of vascular disease
AU5581999A (en) Device to assess efficacy of sterilization procedure
AU2002249891A1 (en) Compounds and methods for the diagnosis and treatment of babesia infection
AUPQ854100A0 (en) Methods for monitoring treatment of helicobacter infection
AU2002363638A1 (en) Compounds and methods for treatment and diagnosis of chlamydial infection